Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Clinical trial NCT04740697 · RECRUITING
Trial details
- NCT number
- NCT04740697
- Sponsor
- Institut Claudius Regaud
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-12
- Primary completion
- 2028-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.